InvestorsHub Logo
icon url

veto

07/06/17 2:31 PM

#110733 RE: art2426 #110716

I am glad you find pain relief from the product but if it was effective to the magnitude many suggest don't you think big pharm/big wallets would be all over Andy with staggering offers. Anecdotal accounts differ from peer reviewed large scale independent trials. The placebo effect alone accounts for a percentage of positive results. Where are the ringing endorsements from the major players in this field? My point was like an aspirin Actipatch has a place in pain management but it has its limitations. As a shareholder I just hope BIEL can somehow manage to succeed in spite of Andy and his sticky fingered relatives. All in my humble opinion